FDA Launches Global Rx Quality Initiative With Plans To Rely On Non-U.S. Regulators
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency restructures staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality but offers few details on upcoming plans.